Santen Pharmaceutical Co., Ltd.

BMV:4536 N Stock Report

Market Cap: Mex$57.7b

Santen Pharmaceutical Management

Management criteria checks 2/4

Santen Pharmaceutical's CEO is Takeshi Ito, appointed in Sep 2022, has a tenure of less than a year. directly owns 0.006% of the company’s shares, worth MX$3.71M. The average tenure of the management team and the board of directors is 2.4 years and 4 years respectively.

Key information

Takeshi Ito

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureless than a year
CEO ownership0.006%
Management average tenure2.4yrs
Board average tenure4yrs

Recent management updates

Recent updates

CEO

Takeshi Ito (64 yo)

less than a year

Tenure

Mr. Takeshi Ito has been President and Chief Executive Officer at Santen Pharmaceutical Co., Ltd. since September 12, 2022 and serves as Representative Director since April 01, 2022. He served as Executive...

Leadership Team

NamePositionTenureCompensationOwnership
Takeshi Ito
Presidentless than a yearno data0.0064%
MX$ 3.7m
Kazuo Koshiji
Chief Financial Officer & Chief Risk Officerno datano datano data
Rie Nakajima
COO & Corporate Officerless than a yearno datano data
Minori Hara
Chief Digital & Information Officer3.2yrsno datano data
Kaori Itagaki
General Manager of Investor Relations Groupno datano datano data
Mika Masunari
General Counsel & Chief Compliance Officer2.7yrsno datano data
Nobuko Kato
Chief Communications Officer1.4yrsno datano data
Satoshi Suzuki
Senior Corporate Officer & Head of Corporate Development Division6.2yrsno datano data
Shinichi Teramachi
Corporate Officer2.4yrsno datano data
Ippei Kurihara
Corporate Officer and Head of Marketing Department2.4yrsno datano data
Takahiro Morita
Global Head of Core Principle & People Centricity1.4yrsno datano data
Kenji Morishima
Corporate Officer & Head of China Product Development Department9.2yrsno datano data

2.4yrs

Average Tenure

Experienced Management: 4536 N's management team is considered experienced (2.4 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Takeshi Ito
President5.9yrsno data0.0064%
MX$ 3.7m
Noboru Kotani
Independent Outside Directorless than a yearno data0.0013%
MX$ 773.8k
Hirofumi Yasuhara
Outside Corporate Auditor4yrsno datano data
Akira Kurokawa
Chairman of the Board26yrsJP¥115.00m0.054%
MX$ 30.9m
Kanoko Oishi
Independent Outside Director8yrsno datano data
Kunihito Minakawa
Independent Outside Director5yrsno data0.00054%
MX$ 311.8k
Yumiko Ito
Outside Corporate Auditor4yrsno datano data
Masahiko Ikaga
Outside Corporate Auditorless than a yearno datano data
Yutaro Shintaku
Independent Outside Director6yrsno datano data
Hiroshi Isaka
Standing Corporate Auditor3.4yrsno data0.00027%
MX$ 155.9k
Tamie Minami
Independent Outside Directorless than a yearno datano data

4.0yrs

Average Tenure

67yo

Average Age

Experienced Board: 4536 N's board of directors are considered experienced (4 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2023/06/13 12:21
End of Day Share Price 2023/03/16 00:00
Earnings2023/03/31
Annual Earnings2023/03/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Santen Pharmaceutical Co., Ltd. is covered by 21 analysts. 10 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Atsushi SekiBarclays
Philip HallBNP Paribas Securities (Asia)
Koichi MameganoBofA Global Research